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In COPD patients the ergogenic effect of heliox or oxygen breathing might be related both to 
improvements in ventilatory parameters (that lessen dyspnoea) and to enhanced oxygen delivery 
to respiratory and locomotor muscles http://bit.ly/2JlJBTc
Case history
A 64-year-old man with a history of long-
term cigarette smoking (>36 pack-years) and 
diagnosis of chronic obstructive pulmonary 
disease (COPD) (forced expiratory volume in 
1s (FEV1): 47% predicted; FEV1/forced vital 
capacity: 61% predicted) was referred to an 
outpatient pulmonary rehabilitation programme 
[1]. The patient exhibited gas trapping at rest 
(residual volume/total lung capacity (TLC): 167% 
predicted; inspiratory capacity (IC)/TLC: 29%) 
and reported exertional dyspnoea at grade 3 on 
the 1–5 Medical Research Council scale [2]. The 
patient’s medication included bronchodilators 
and inhaled steroids. The patient poorly tolerated 
the cardiopulmonary exercise test (sustained at 
75% of his peak exercise capacity, WRpeak). 
This was demonstrated by substantially reduced 
endurance time (6 min 30 s), profound dynamic 
hyperinflation (reduction in IC from rest by 
232 mL), moderate exertional hypoxaemia (arterial 
oxygen saturation measured by pulse oximetry 
(SpO2) 87%) and reported severe breathlessness as 
the predominant reason for terminating exercise 
(i.e. score of 8 on the 1–10 Borg scale [3]) (table 1).
Question
How can we enhance patient’s poor exercise 
tolerance during rehabilitation?
Answer
Testing procedures
The patient underwent two constant-load cycling 
exercise tests on two different days, each sustained 
at 75% WRpeak while breathing normoxic helium 
(helium 79% and oxygen 21%, heliox) or pure 
(100%) oxygen [4].
Ventilatory responses 
and symptoms
Table 1 presents the results of the exercise tests 
regarding ventilatory responses and symptoms 
scores. As expected, endurance time was 
prolonged during heliox and oxygen administration 
as compared to normoxia (by 64% and 72%, 
respectively). At isotime (i.e. data that were obtained 
on heliox or oxygen trials at the same time point 
as at the limit of tolerance in room air), V′E was 
greater compared to normoxia with heliox breathing 
secondary to greater VT; during oxygen breathing V′E 
was lower compared to room air breathing due to a 
reduction in breathing frequency and VT (table 1). 
Furthermore, IC, inspiratory time and duty cycle of 
inspiration were higher and VT/IC ratio (an index of 
ventilatory reserves and VT constraint) was lower 
during heliox or oxygen breathing compared with 
breathing room air. Dyspnoea and leg fatigue scores 
at isotime were lower on both heliox and oxygen 
breathing trials compared with normoxia.
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Central haemodynamic responses
Figure 1 presents the central haemodynamic 
responses during heliox and oxygen breathing. 
At isotime, while breathing heliox, cardiac output 
and systemic vascular conductance were greater 
compared with room air breathing (figures 1a and 
1b). At rest and during exercise breathing oxygen, 
arterial oxygen content (CaO2) was greater compared 
with normoxia (figure 1c). Accordingly, systemic 
oxygen delivery during both heliox and oxygen 
breathing was greater compared with room air 
breathing (figure 1d).
Respiratory and locomotor 
muscle haemodynamic and 
oxygenation responses
Figures 2 and 3 present the results of respiratory 
and locomotor muscle haemodynamic and 
oxygenation responses. At isotime, during heliox 
breathing, respiratory and locomotor muscle 
blood flow was greater compared with room air 
breathing (figure 2a–c). Furthermore, respiratory 
and locomotor muscle oxygen delivery during 
both heliox and oxygen breathing were greater 
(figure 2d–f) and the respiratory and locomotor 
muscle oxygen desaturation was lower compared 
Table 1 Constant load exercise data at 75% WRpeak
Variables Normoxia Normoxic helium 100% oxygen
Endurance time s 390 640 670
tlim Isotime Isotime
V′E L·min−1 43.7 48.6 37.4
VT L 1.68 1.87 1.56
Breathing frequency 
breaths·min−1
26 26 24
tI s 0.69 0.99 0.98
tI/ttot % 34 43 46
ΔIC L −0.232 0.080 −0.090
VT/IC ratio 0.76 0.74 0.66
SaO2 % 87 91 99
Borg dyspnoea score 8 5 5
Borg leg fatigue score 6 5 4
Isotime data are those obtained on normoxic heliox and 100% oxygen at the 
same time as at the limit of tolerance (tlim) on room air. WRpeak: peak work rate 
at the preliminary incremental test in room air; V′E: minute ventilation; VT: tidal 
volume; tI: inspiratory time; tI/ttot: duty cycle of inspiration; ΔIC: change in IC 
from baseline; SaO2: arterial oxygen saturation.
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Figure 1 Central haemodynamic responses. a) Cardiac output; b) systemic vascular conductance; c) systemic CaO2; and d) 
systemic oxygen delivery recorded at rest, at the time of exhaustion in room air (isotime), and at the limit of exercise tolerance 
(tlim) while breathing normoxic heliox, pure (100%) oxygen or room air. Isotime data are those obtained on normoxic heliox 
or 100% oxygen at the same time as at the limit of exercise tolerance on room air.
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with room air breathing (figure 3a–c). In addition, 
arterial lactate concentration during both heliox 
and oxygen breathing was lower than room air 
breathing (figure 3d).
Discussion
Summary of the physiological 
effects of heliox and oxygen 
breathing during exercise
Collectively the findings indicate that the increase in 
endurance time during heliox or oxygen breathing 
can be attributed to a number of physiological 
adjustments associated with improvements in 
respiratory, cardiovascular and muscle cellular 
metabolic responses. The improvement in 
ventilatory response was accompanied by lower 
dyspnoea and leg fatigue perceptions during both 
supplementations (table 1) and by a lower degree 
of reduction in respiratory (both inspiratory and 
expiratory) and locomotor muscle oxygen saturation 
compared with room air (figure 3). Increases 
in respiratory and locomotor muscle oxygen 
availability by heliox and oxygen administration 
were due to higher systemic oxygen delivery (figure 
1) albeit for different reasons; namely, greater 
cardiac output and local muscle perfusion with 
heliox administration (figures 1 and 2) and higher 
arterial oxygen concentration with oxygen breathing 
(figure 1). In conclusion, along with the alleviation 
of ventilatory constraints by heliox and oxygen 
breathing compared with room air (table 1) [5], a 
common basis for enhanced endurance time by 
heliox or oxygen administration is the improved 
respiratory and locomotor muscle oxygen delivery 
and reduced metabolic acidosis and sensations of 
breathlessness and leg discomfort afforded by both 
interventions (figure 4) [4].
Heliox and oxygen breathing on 
reducing dyspnoea during exercise
As far as dyspnoea is concerned, an interesting 
observation in this case is the fact that heliox 
and oxygen acted differently on the reduction of 
exertional dyspnoea. Specifically, during exercise, 
heliox increased V′E (by shifting the operating lung 
volumes downward) but oxygen decreased V′E 
compared with room air breathing (table 1) [4–9]. 
Nevertheless, during both interventions the patient 
reported less shortness of breath (table 1), either 
through making him breathe less (with oxygen) or 
making him breathe more but with less constraints 
(heliox). Indeed, heliox supplementation as an 
ergogenic strategy is based on the idea that a lighter 
gas mixture could be moved to and from the lung 
airways more easily than atmospheric air [6, 7]. 
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Figure 2 Quadriceps, intercostal, and abdominal muscle haemodynamic responses. a) Quadriceps muscle blood flow; b) intercostal muscle blood flow; 
c) abdominal muscle blood flow; d) quadriceps muscle oxygen delivery; e) intercostal muscle oxygen delivery; and f) abdominal muscle oxygen delivery recorded 
at rest, at the time of exhaustion in room air (isotime), and tlim breathing normoxic heliox, pure (100%) oxygen or room air. Isotime data are those obtained on 
normoxic heliox or 100% oxygen at the same time as at the limit of exercise tolerance on room air.
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Heliox reduces turbulent airway resistance and both 
inspiratory and expiratory pressures during exercise 
as compared with room air breathing [8, 9]. Due to 
these effects, the patient demonstrated higher V′E, 
less dynamic hyperinflation (expressed as change in 
IC from rest) and improved cardiac function during 
exercise when compared to room air breathing 
(table 1 and figure 1) [4, 9–11].
However, it is known that oxygen administration 
primarily increases arterial oxygen concentration 
but also lessens V′E (table 1) and ventilatory drive, 
potentially via inhibition of carotid bodies and/
or improved metabolic conditions of the skeletal 
muscles (manifested by increases in intracellular 
pressure of oxygen and concentrations of 
phosphocreatine and a reduction in intracellular 
concentrations of inorganic phosphate) [5, 10, 12].
The effects of oxygen supplementation on operating 
lung volumes (end-inspiratory and end-expiratory 
lung volumes), VT, breathing pattern and exercise 
induced-dynamic hyperinflation might be more 
pronounced in hypoxaemic patients as compared 
to normoxic or to patients with mild arterial 
oxygen desaturation [13–15]. Furthermore, it 
has been postulated that patients who exhibit a 
reduction in dynamic hyperinflation in response 
to oxygen breathing appear to have greater airway 
obstruction, greater ventilatory constraints during 
exercise and poorer exercise performance with 
steeper dyspnoea/ventilation slopes as compared 
to their counterparts [12, 16]. Therefore, it can be 
argued that during exercise hypoxaemic patients 
might experience greater reduction in dyspnoea 
sensations in response to reductions in V′E following 
oxygen administration [12, 15].
Heliox and oxygen breathing: 
central and local haemodynamic 
responses during exercise
The mechanisms orchestrating the ergogenic 
effect of heliox and oxygen breathing on exercise 
capacity were not limited to the alleviation of 
ventilatory constraints during exercise. The results 
from this case and other studies suggest that 
extrapulmonary improvements could potentially 
alleviate exercise induced-dyspnoea in patients 
with COPD [17, 18]. Furthermore, during heliox 
and oxygen breathing the patient exhibited 
improved respiratory and locomotor muscle 
metabolic condition as indicated by the smaller 
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Figure 3 Quadriceps, intercostal, and abdominal muscle oxygenation responses and metabolic responses. a) Quadriceps 
muscle oxygen saturation; b) intercostal muscle oxygen saturation; c) abdominal muscle oxygen saturation; and d) arterial 
lactate concentration recorded at rest, at the time of exhaustion in room air (isotime), and tlim while patient breathed norm­
oxic heliox, pure (100%) oxygen or room air. Isotime data are those obtained on normoxic heliox or 100% oxygen at the 
same time as at the limit of exercise tolerance on room air.
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decrease in local muscle oxygenation that was 
accompanied by less lactic acidosis as compared 
with room air (figure 3). These beneficial effects 
are of critical importance when considering that 
exercise-induced respiratory and leg muscle 
fatigue can contribute to the increase in dyspnoea 
perceptions [19, 20]. Indeed, in the neurobiological 
model of dyspnoea proposed by Dempsey et al. [19] 
neural inputs that reach the somatosensory cortex 
and contribute to dyspnoea sensations originate 
from the locomotor and respiratory muscles via 
the group III–IV muscle afferents. During exercise 
in room air, a restriction in oxygen delivery to the 
respiratory and locomotor muscles occurs due 
to the inability of the circulatory system to fully 
satisfy their energy demands [21]. This, in turn, 
could exaggerate both respiratory and locomotor 
muscle fatigue and thus further increase dyspnoea 
perceptions during exercise. Furthermore, during 
heliox and oxygen breathing the greater increase in 
respiratory and locomotor muscle oxygen delivery 
compared with room air may have postponed 
exercise-induced skeletal muscle fatigue and 
thus alleviated muscle sensory afferent traffic 
in type III–IV nerves innervating the respiratory 
and locomotor muscle, also contributing to the 
reduction in dyspnoea sensations (table 1). In 
addition, reductions in ventilatory drive with 
oxygen breathing in patients with COPD during 
exercise have been associated with reduced 
peripheral chemoreceptor afferent activity [22]. 
Importantly, Gosselin et al. [23] demonstrated 
that oxygen supplementation can reduce 
quadriceps muscle electromyogram activity at 
any given work rate compared with exercise in 
room air.
In summary, the beneficial effects of 
supplemental heliox and oxygen on respiratory and 
locomotor muscle metabolic and muscle contractile 
function would be expected to delay the onset of 
lactic acidosis accompanied by improvements in 
dyspnoea, leg discomfort and exercise tolerance 
in patients with COPD. In support of this notion, 
significant associations between the improvement 
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Figure 4 A schematic representation conceptualising the acute physiological responses a patient with COPD exhibits during exercise breathing heliox or oxy­
gen compared with exercise in room air. tE: expiratory time; DH: dynamic hyperinflation; CO: cardiac output; O2DEL: oxygen delivery; SVC: systemic vascular 
conductance; EMG: electromyography. #: profoundly in hypoxaemic patients. Figure partially created using BioRender.
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in respiratory muscle oxygen delivery and the 
lower lactic acidosis and dyspnoea perceptions 
reported during exercise while breathing heliox 
or oxygen compared with room air were recently 
demonstrated [24]. A conceptual representation 
of the effect of heliox and oxygen breathing during 
exercise is presented in figure 4.
Clinical perspectives 
and future directions
Over the past two decades a number of research 
studies have documented that acute administration 
of heliox and oxygen prolongs endurance cycling 
time or walking distance during the 6-min walk test 
(6MWT) and shuttle walking tests [25–27]. Heliox 
and oxygen supplementation have been shown 
to increase peak exercise capacity during cycling 
compared with breathing air [28]. Evidence does also 
support the ergogenic effect of heliox and oxygen 
breathing on exercise capacity during small mass 
exercise (i.e. leg knee extension) [29]. Nevertheless, it 
has been shown that not all patients with COPD can 
benefit from heliox supplementation. The noticeable 
effects of heliox breathing on exercise capacity may 
be more pronounced in those patients exhibiting 
more severe airflow obstruction and a greater degree 
of ventilatory limitation during exercise [25, 30].
The increase in the concentration of oxygen 
(helium-hyperoxia) in the inhaled gas (i.e. 72%He– 
28%O2, 70%He–30%O2 or 60%He–40%O2) has 
shown to have an additive effect, leading to more 
advantageous improvement in exercise capacity 
(i.e. shuttle walking, 6MWT or constant-load 
cycling) than those observed with oxygen or heliox 
alone in patients with mild-to-moderate arterial 
hypoxaemia during exercise [25–27]. Specifically, 
an optimal combination of helium and oxygen, 
such as 60%He–40%O2, has been demonstrated to 
greater reduce the resistive work of breathing and the 
work to overcome intrinsic positive end-expiratory 
pressure compared with hyperoxia (i.e. nitrogen 
60% and oxygen 40%) or heliox (helium 79% and 
oxygen 21%) alone [26]. In addition, by inspiring 
helium-hyperoxia gas mixture, patients’ SaO2 was 
significantly higher than on heliox and comparable 
to that during hyperoxia, thus further justifying the 
advantages of using helium-hyperoxia gas mixture 
in the clinical setting in patients with COPD [26]. By 
contrast, supplemental oxygen can improve exercise 
capacity and dyspnoea sensations in patients with or 
without exercise-induced hypoxaemia. Furthermore, 
it has been documented that the plateauing effect of 
oxygen on improving exercise tolerance, operational 
lung volumes and inspiratory flows and dyspnoea 
ratings in non-hypoxaemic COPD patients is optimal 
at inspiratory oxygen fractions of 0.5 [31].
Evidence from randomised controlled trials [25, 
32–34], that investigated whether breathing heliox 
and oxygen administration during rehabilitative 
exercise could enhance physiological training 
effects in patients with COPD, suggested that the 
improvement may be apparent only when heliox 
and oxygen allow a higher training load to be 
applied than the standard practice of rehabilitation 
with medical air [35]. In this context, a recent 
study by Alison et al. [36], investigated whether 
supplemental oxygen during an 8-week supervised 
exercise training programme (intervention group) 
was more effective than room air training (sham 
group) in improving exercise, functional capacity 
and quality of life in patients with COPD. Despite 
the significant increase in exercise capacity and 
quality of life that was observed following the 
exercise training period in both groups, the study 
did not reveal greater benefits during training with 
supplemental oxygen compared with room air. The 
oxygen breathing group did not achieve a greater 
training dose per session than the room air group 
despite significantly lower dyspnoea and perceived 
exertion scores that were reported during training 
sessions. Nevertheless, if the progression of training 
intensity was standardised to elicit the same level 
of dyspnoea and/or rate of perceived exertion as 
in the room air group, this potentially might have 
Self-evaluation questions
1) Compared with room air, heliox and oxygen breathing increase 
exercise endurance time in patients with COPD by which of the 
following mechanism(s)?
a) Lessening the ventilatory constrains
b) Improving cardiac output
c) Improving respiratory and locomotor muscle oxygen delivery
d) a and b
e) a and c
2) Which of the following statements best reflects the acute 
physiological responses during exercise while breathing heliox or 
oxygen in COPD?
a) Both heliox and oxygen improve cardiac output and arterial oxygen 
content
b) Heliox improves cardiac output, local muscle perfusion and oxygen 
arterial oxygen content
c) Both heliox and oxygen improve cardiac output and muscle oxygen 
delivery
d) Both heliox and oxygen improve muscle perfusion and arterial 
oxygen content
3) Concerning dyspnoea perceptions in patients with COPD during 
exercise, which of the following statement(s) is/are correct?
a) Heliox reduces turbulent airway resistances and oxygen reduces V′E 
during exercise as compared to room air
b) Heliox and oxygen improve local muscle oxygenation during 
exercise and reduce arterial lactate concentration compared with 
room air
c) Improving respiratory and locomotor muscle oxygen delivery by 
heliox and oxygen supplementation might postpone exercise-
induced muscle fatigue
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resulted in greater functional and clinical benefits 
in the oxygen training group.
Conclusion
In patients with COPD the ergogenic effect of 
heliox or oxygen breathing might be related not 
only to improvement in ventilatory parameters 
that contribute to lessen dyspnoea but also to 
enhanced oxygen delivery to respiratory and 
locomotor muscles. Rehabilitative exercise 
training interventions using heliox or oxygen 
supplementation should focus on increasing 
training intensity for achieving greater physiological 
training benefits.
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